Thursday, August 17, 2017 4:24:52 PM
It should serve as a bare minimum to investors at this point.
For me, as I speculate that IMUN is "Dump and Pump", therefore they demote rather than promote, the management not updating the powerpoint on www.cytocom.com, a private company, seems pretty in line with their mission of wanting to keep quiet and keep the stock price low. All my opinion. Why should they update it if they don't have to? They're clearly not trying to promote it, and there are no laws stating they have to update their info. It's a private company.
Noreen has said that IMUN shareholders will be updated on the status of all Cytocom trials "following the launch of Lodonal [in Nigeria]".
LDN for Crohn's has the potential to be the biggest revenue generator - I think. I could be wrong on that. LDN has been shown to be most effective for Crohn's though, compared to any other disease, I believe. However, that's Cytocom revenue so only about 1/8 of it is for IMUN shareholders (as of current structure).
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM